Company: PTHS
Filing Date: 2025-09-16
Form Type: 8-K/A
Source: 0001753926-25-001500
Chunk: 93

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-09-16
Form: 8-K/A
Chunk 93
---
, as defined under the rules of the SEC and the applicable NYSE American listing rules and has sufficient knowledge in
financial and auditing matters to serve on the Company’s audit committee. Mr. Friedberg is the chairperson of the audit
committee. Mr. Friedberg is an “audit committee financial expert” as defined in Item 407(d)(5)(ii) of Regulation
S-K promulgated under the Securities Act and currently serves as chair of the audit committee for Channel. This designation does
not impose any duties, obligations or liabilities that are greater than those generally imposed on members of the Company’s
audit committee and the board of directors. Our audit committee will be directly responsible for, among other things:

| • | our                                                                                                                                   
 accounting and financial reporting processes, including its financial statement audits and the integrity of its financial statements; |

| • | our                                                
 compliance with legal and regulatory requirements; |

| • | reviewing                                  
 and approving related person transactions; |

| • | selecting                                                               
 and hiring the Company’s registered independent public accounting firm; |

| • | the                                                                                     
 qualifications, independence and performance of the Company’s independent auditors; and |

| • | the                                                                                     
 preparation of the audit committee report to be included in our annual proxy statement. |

Compensation Committee

Our
compensation committee is composed of Messrs. Pauls and Malamut, each of whom qualifies as an independent director, as defined
under applicable NYSE American listing rules and also meets the additional, heightened independence criteria applicable to members
of the compensation committee. Mr. Pauls is the chairperson of the compensation committee.

Our compensation committee will be responsible for, among other things:

| • | evaluating,                                                                                                                   
 recommending, approving and reviewing executive officer and director compensation arrangements, plans, policies and programs; |

| • | administering                                           
 our cash-based and equity-based compensation plans; and |

| • | making                                                                                                                               
 recommendations to our board of directors regarding any other board of director responsibilities relating to executive compensation. |

Nominating and Corporate Governance Committee

Our
nominating and corporate governance committee is composed of Messrs. Greenleaf and Malamut, each of whom qualifies as an independent
director, as defined under applicable NYSE American listing rules. Mr. Pauls is the chairperson of the nominating and corporate
governance committee.

Our nominating and corporate governance committee will be responsible for, among other things:

| • | identifying,                                                                      
 considering and recommending candidates for membership